Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 2, 2008, Pages 143-147

  Zhou, T ^a   Xu, C ^a   He, M ^a   Sun, Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADICAL RETROPUBIC PROSTATECTOMY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ERYTHROPOIETIN; UP-REGULATION;

EID: 43549121527     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500995     Document Type: Article

References (31)

1. Krantz SB. Erythropoietin. Blood 1991; 77: 419-434.
2. Jones SS, D'Andrea AD, Haines LL, Wong GG. Human erythropoietin receptor: Cloning, expression, biological characterization. Blood 1990; 76: 31-35.
3. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938.
4. D'Andrea AD, Fasman GD, Lodish HF. A new hematopoietic growth factor receptor superfamily: Structural features and implications for signal transduction. Curr Opin Cell Biol 1990; 2: 648-651.
5. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999; 283: 987-990.
6. Remy I, Wilson IA, Michnick SW. Erythropoietin receptor activation by a ligand-induced conformation change. Science 1999; 283: 990-993.
7. Wojchowski DM, Gregory RC, Miller CP, Pandit AK, Pircher TJ. Signal transduction in the erythropoietin receptor system. Exp Cell Res 1999; 253: 143-156.
8. Juul SE. Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol 2000; 27: 527-541.
9. Masuda S, Naguo M, Takahata K, Konosh Y, Gallyas Jr F, Tabira T et al Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993; 268: 11208-11216.
10. Moritz KM, Lim GB, Wintour. EM. Developmental regulation of erythropoietin and erythropoiesis. Am J Physiol 1997; 273: R1829-R1844.
11. Sasaki R, Masucla S, Nagao M. Erythropoietin: Multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 2000, 64: 1775-1793.
12. Acs G, Zhang PJ, Rebbeck TR, Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002; 95: 969-981.
13. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 2001; 61: 3561-3565.
14. Selzer E, Wacheck V, Kodym R, Schlagbauer-Wadl H, Schlegel W, Pehamberger H et al. Erythropoietin receptor expression in human melanoma cells. Melanoma Res 2000; 10: 421-426.
15. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 2000; 58: 647-657.
16. Yasuda Y, Fujita Y, Masuda S, Musha T, Ueda K, Tanaka H et al. Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 2002; 23 1797-1805.
17. Ribatti D, Marzullo A, Nico B, Crivellato E, Ria R, Vacca A. Erythropoietin as an angiogenic factor in gastric carcinoma. Histopathology 2003; 42: 246-250.
18. Batra S, Perelman N, Luck LR, Shimada H, Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 2003; 83: 1477-1487.
19. Gaffen SL, Lai SY, Longmore GD, Liu KD, Goldsmith MA. Genetic evidence for an additional factor required for erythropoietin induced signal transduction. Blood 1999; 94: 74-86.
20. Leyland-Jones B, BEST Investigators Study Group. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003; 4: 459-460.
21. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B et al. Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 2003; 362: 1255-1260.
22. Muller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 2001; 1: 87-92.
23. Feldman L, Wang Y, Rhim J, Sytkowski AJ. Human prostate epithelial cells and prostate cancer cells express functional erythropoietin receptors and respond to erythropoietin in vitro. Exp Hematol 2002; 30 (6 Suppl 1): 61.
24. Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 2006; 66: 135-145.
25. Arcasoy MO, Amin K, Vollmer RT, Jiang X, Demark-Wahnefried W, Haroon ZA. Erythropoietin and erythropoietin receptor expression in human prostate cancer. Mod Pathol 2004; 18: 421-430.
26. McNeal JE, Bostwick DG. Intraductal dysplasia: A pre-malignant lesion of the prostate. Hum Pathol 1986; 17: 64-71.
27. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A et al. Hypoxia-inducible erythropoietin signaling in squamous, dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 2003; 162: 1789-1806.
28. Bonkhoff H, Stein URemberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994; 24: 114-118.
29. McNeal JE, Haillot O, Yemoto C. Cell proliferation in dysplasia of the prostate: Analysis by PCNA immunostaining. Prostate 1995; 27 258-268.
30. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M et al Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 1993; 143: 390-400.
31. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576-1582.